发明名称 Treatment of statin side effects using uridine derivatives
摘要 Disclosed is a composition for treatment of one or more side effects of statin therapy comprising uridine, a biological precursor or derivative of uridine derived from or converted to uridine in vivo in one to four steps or a salt, ester or tautomer thereof in association with one or more pharmaceutically acceptable additives and at least one statin. Also disclosed is the use of uridine, a biological precursor or derivative of uridine derived from or converted to uridine in vivo in one to four steps or a salt, ester or tautomer thereof in preparation of a medicament for treatment of one or more side effects of statin therapy.
申请公布号 NZ533382(A) 申请公布日期 2007.03.30
申请号 NZ20020533382 申请日期 2002.12.13
申请人 MAGRAL LIMITED 发明人 LINNANE, ANTHONY WILLIAM
分类号 A61K31/505;A61K31/22;A61K31/366;A61K31/40;A61K31/4418;A61K31/7068;A61K31/7072;A61P1/08;A61P3/06;A61P9/04;A61P9/10;A61P25/00;A61P25/20;A61P27/16;A61P29/00;A61P43/00;(IPC1-7):A61K31/22;A61K31/707 主分类号 A61K31/505
代理机构 代理人
主权项
地址